Score Your Stock

LACMED LAC MED BERHAD

5341.KL · Health Care · Health Care Equipment & Services
Bottom 40% of scored stocks
Compare with nearby peers
OkayBottom 40% of scored stocks
ShariahWeak SpotOne-off DividendLimited Data

LACMED scores 44/100 on fundamentals: in the bottom 40% of 1120 scored Bursa Malaysia stocks. Its strongest area is Financial Safety (100/100); its weakest is Price Fairness (17/100). It carries 3 warning flags: Weak Spot, One-off Dividend, Limited Data.

Best
Financial 100
Weakest
Price 17
  • Carries a Weak Spot flag
  • Carries a One-off Dividend flag
  • Carries a Limited Data flag
Mkt capRM 272.0m#446 of 1113 in BursaEPSRM 0.05P/E15×✓ vs sector avg 26.8×P/B2.2×✗ vs sector avg 1.8×Div yieldNo dividends paid✓ Top 47% in Bursa52w range · 4% of range0.651.34
as of 18 Oct 2026

Nearby peers

Ranks #19 of 30 in Health Care by score

#1DPHARMA85#17CENGILD48#18TOPVISN44
#19LACMED44
#20LYC42#21SMILE41

One-Minute Summary

Why LACMED scores 44

A financially strong stock, but price fairness needs attention.

What looks good
What to watch

After Jun '26 results: 66 → 66See all movers →

Business Strength

38
Why 38?
Pillar score: (1 + 1 + 0 + 1) = 3 of 8 points → 38 · 1 N/A skipped
Return on Equity (ROE)15%Okay4-Year Revenue Growth+7%/yrOkay4-Year Profit Growth-4%/yrWeakNet Profit Margin10%OkayQuarterly MomentumNo dataN/A
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↓ -12.1%Equity ↑ +207%ROE % 14.9%
Net ProfitEquityROE %
21m20m22m18m40m48m119m123m202320242025TTM51.9%42.7%18.4%14.9%

Revenue & Net Profit, with Net Margin

Revenue ↑ +20.9%Net Profit ↓ -12.1%Net Margin % 10%
RevenueNet ProfitNet Margin %
150m183m202m182m21m20m22m18m202320242025TTM13.8%11.1%10.9%10%

Sales grew about 20.9% over 4 years: customers keep spending more with this company.

Profit fell about 12.1% from where it was 4 years ago: the boom has cooled off.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↓ -42.1%Net Profit ↓ -45.9%Net Margin % 11.6%
RevenueNet ProfitNet Margin %
79m29m46m10m1m5mDec '25Mar '26Jun '2612.5%3.4%11.6%

Sales fell about 42.1% over the last 3 quarters: worth watching why.

Profit fell about 45.9% over the last 3 quarters.

Why 100?
Pillar score: (2 + 2 + 2) = 6 of 6 points → 100
Debt-to-Equity0.3×StrongCurrent Ratio2.1×StrongInterest Coverage26.5×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↑ +54.9%Equity ↑ +207%D/E 0.3×
Total DebtEquityD/E
26m20m28m40m40m48m119m123m202320242025TTM0.6×0.4×0.2×0.3×

Borrowings grew about 54.9% over 4 years: watch this; rising debt adds pressure in bad times.

Short-term assets vs bills, with Current Ratio

Current Assets ↑ +55.5%Current Liabilities → +2.5%Current Ratio 2.1×
Current AssetsCurrent LiabilitiesCurrent Ratio
136m124m222m212m98m79m116m100m202320242025TTM1.4×1.6×1.9×2.1×
Why 25?
Pillar score: (0 + 0 + 0 + 2) = 2 of 8 points → 25
Dividend QualityNo dividends paidWeak
Payout ratio: 42%
Operating Cash FlowNegative recentlyWeakFree Cash FlowNegative recentlyWeakCash & Cash EquivalentsGrowing & covers near-term debtStrong
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↓ -204.9%Free CF ↓ -271.4%
Operating CFFree CF
23m31m1m-24m22m30m-12m-37m202320242025TTM

Cash flow has been weak or negative recently: the business is burning cash, not building it.

Cash vs Total Debt

Cash ↑ +31.1%Short-Term Debt ↑ +38.8%Total Debt ↑ +54.9%
CashShort-Term DebtTotal Debt
31m16m65m40m23m19m26m32m26m20m28m40m202320242025TTM

Dividends per Share, with Yield

DPS (sen) → +0%Yield % 0.9%
DPS (sen)Yield %
000020222023202420250.9%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 17?
Pillar score: (1 + 0 + 0) = 1 of 6 points → 17
P/E Ratio15×OkayP/B Ratio2.2×WeakPEG Ration/m (growth not measurable)Weak
Show chart

Score vs Share Price

Score (0-100)Share price
RM 1.24RM 0.96RM 0.68100500Dec '25Mar '26Jun '26Oct '26📊💰📊

The share price is down about 13.3% since 2025.

What happened, and how the price moved

Why 40?
Pillar score: (1 + 0 + 2 + 1 + 0) = 4 of 10 points → 40 · 1 N/A skipped
Earnings ConsistencyUnevenOkayDebt Trend (4yr)RisingWeakShare Count Trend (4yr)+0%/yrStrongInventory vs Sales (4yr)+7.1 pp/yr vs salesOkayAsset Turnover Trend (4yr)-26.2%WeakQuarterly ConsistencyNo dataN/A
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +20.9%Inventory ↑ +46.8%Inv. % of Rev. 17.4%
RevenueInventoryInv. % of Rev.
150m183m202m182m22m21m28m32m202320242025TTM14.4%11.4%13.8%17.4%

Get an email when LACMED's score changes, and why

Own more than one stock? Check them all at once ›
Ranks #19 of 30 in Health Care by score

Sector peers

#1DPHARMA85#17CENGILD48#18TOPVISN44
#19LACMED (you)44
#20LYC42#21SMILE41

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDividend Payout RatioDiv yieldP/E RatioP/B RatioPEG Ratio
2026RM 181.7mRM 18.2mRM -23.7mRM -37.2mRM -13.5mRM 40.0mRM 39.8mRM 32.2mRM 122.5mRM 211.6mRM 99.9mRM 228.5mRM 106.0mRM 31.7m-15%10%0.3×2.1×26.5×42%----
2025RM 201.6mRM 21.9mRM 0.6mRM -11.6mRM -12.2mRM 64.9mRM 27.5mRM 26.1mRM 118.8mRM 221.5mRM 116.2mRM 236.2mRM 117.4mRM 27.8mRM 0.0m18%11%0.2×1.9×41.3×23%0%15.9×2.9×0.8
2024RM 183.2mRM 20.4mRM 30.7mRM 30.2mRM -0.5mRM 15.8mRM 20.4mRM 18.9mRM 47.8mRM 124.0mRM 78.8mRM 128.1mRM 80.2mRM 20.8mRM 0.0m43%11%0.4×1.6×55.7×91%----
2023RM 150.3mRM 20.7mRM 22.6mRM 21.7mRM -0.9mRM 30.5mRM 25.7mRM 23.2mRM 39.9mRM 136.1mRM 97.5mRM 139.6mRM 99.7mRM 21.6mRM 0.0m52%14%0.6×1.4×26.4×19%----